Effect of oral administration of dantrolene sodium on serum creatine kinase activity after exercice in horses with recurrent exertional rhabdomyolysis

Erica C. McKenzie, Stephanie J. Valberg, Sandra M. Godden, Carrie J Finno, Michael J. Murphy

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Objective - To determine the effect of oral administration of dantrolene sodium on serum creatine kinase (CK) activity after exercise in horses with recurrent exertional rhabdomyolysis (RER). Animals - 2 healthy horses and 5 Thoroughbreds with RER. Procedure - 3 horses received 2 doses of dantrolene (4, 6, or 8 mg/kg, PO, with and without withdrawal of food) 2 days apart; 90 minutes after dosing, plasma dantrolene concentration was measured spectrofluorometrically. On the basis of these results, 5 Thoroughbreds with RER from which food was withheld received dantrolene (4 mg/kg) or an inert treatment (water [20 mL]) orally 90 minutes before treadmill exercise (30 minutes, 5 d/wk) during two 3-week periods. Serum CK activity was determined 4 hours after exercise. Plasma dantrolene concentration was measured before and 90 minutes after dosing on the first and last days of dantrolene treatment and before dosing on the first day of the inert treatment period. Results - 90 minutes after dosing, mean ± SEM plasma dantrolene concentration was 0.62 ± 0.13 and 0 μg/mL in the dantrolene and inert treatment groups, respectively. Serum CK activity was lower in dantrolene-treated horses (264 ± 13 U/L), compared with activity in water-treated horses (1,088 ± 264 U/L). Two horses displayed marked muscle stiffness on the inert treatment. Conclusions and Clinical Relevance - In 5 horses with RER from which food had been withheld, 4 mg of dantrolene/kg administered orally provided measurable, though variable, plasma concentrations and significantly decreased serum CK activity after exercise in 4 of those horses.

Original languageEnglish (US)
Pages (from-to)74-79
Number of pages6
JournalAmerican Journal of Veterinary Research
Volume65
Issue number1
DOIs
StatePublished - Jan 2004
Externally publishedYes

Fingerprint

rhabdomyolysis
Dantrolene
Rhabdomyolysis
creatine kinase
Creatine Kinase
oral administration
Horses
Oral Administration
sodium
horses
Serum
exercise
Food
exercise equipment
water treatment
water activity
Water Purification
Therapeutics
muscles

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Effect of oral administration of dantrolene sodium on serum creatine kinase activity after exercice in horses with recurrent exertional rhabdomyolysis. / McKenzie, Erica C.; Valberg, Stephanie J.; Godden, Sandra M.; Finno, Carrie J; Murphy, Michael J.

In: American Journal of Veterinary Research, Vol. 65, No. 1, 01.2004, p. 74-79.

Research output: Contribution to journalArticle

@article{f2f975dafae94c69a9a50e78726c3096,
title = "Effect of oral administration of dantrolene sodium on serum creatine kinase activity after exercice in horses with recurrent exertional rhabdomyolysis",
abstract = "Objective - To determine the effect of oral administration of dantrolene sodium on serum creatine kinase (CK) activity after exercise in horses with recurrent exertional rhabdomyolysis (RER). Animals - 2 healthy horses and 5 Thoroughbreds with RER. Procedure - 3 horses received 2 doses of dantrolene (4, 6, or 8 mg/kg, PO, with and without withdrawal of food) 2 days apart; 90 minutes after dosing, plasma dantrolene concentration was measured spectrofluorometrically. On the basis of these results, 5 Thoroughbreds with RER from which food was withheld received dantrolene (4 mg/kg) or an inert treatment (water [20 mL]) orally 90 minutes before treadmill exercise (30 minutes, 5 d/wk) during two 3-week periods. Serum CK activity was determined 4 hours after exercise. Plasma dantrolene concentration was measured before and 90 minutes after dosing on the first and last days of dantrolene treatment and before dosing on the first day of the inert treatment period. Results - 90 minutes after dosing, mean ± SEM plasma dantrolene concentration was 0.62 ± 0.13 and 0 μg/mL in the dantrolene and inert treatment groups, respectively. Serum CK activity was lower in dantrolene-treated horses (264 ± 13 U/L), compared with activity in water-treated horses (1,088 ± 264 U/L). Two horses displayed marked muscle stiffness on the inert treatment. Conclusions and Clinical Relevance - In 5 horses with RER from which food had been withheld, 4 mg of dantrolene/kg administered orally provided measurable, though variable, plasma concentrations and significantly decreased serum CK activity after exercise in 4 of those horses.",
author = "McKenzie, {Erica C.} and Valberg, {Stephanie J.} and Godden, {Sandra M.} and Finno, {Carrie J} and Murphy, {Michael J.}",
year = "2004",
month = "1",
doi = "10.2460/ajvr.2004.65.74",
language = "English (US)",
volume = "65",
pages = "74--79",
journal = "American Journal of Veterinary Research",
issn = "0002-9645",
publisher = "American Veterinary Medical Association",
number = "1",

}

TY - JOUR

T1 - Effect of oral administration of dantrolene sodium on serum creatine kinase activity after exercice in horses with recurrent exertional rhabdomyolysis

AU - McKenzie, Erica C.

AU - Valberg, Stephanie J.

AU - Godden, Sandra M.

AU - Finno, Carrie J

AU - Murphy, Michael J.

PY - 2004/1

Y1 - 2004/1

N2 - Objective - To determine the effect of oral administration of dantrolene sodium on serum creatine kinase (CK) activity after exercise in horses with recurrent exertional rhabdomyolysis (RER). Animals - 2 healthy horses and 5 Thoroughbreds with RER. Procedure - 3 horses received 2 doses of dantrolene (4, 6, or 8 mg/kg, PO, with and without withdrawal of food) 2 days apart; 90 minutes after dosing, plasma dantrolene concentration was measured spectrofluorometrically. On the basis of these results, 5 Thoroughbreds with RER from which food was withheld received dantrolene (4 mg/kg) or an inert treatment (water [20 mL]) orally 90 minutes before treadmill exercise (30 minutes, 5 d/wk) during two 3-week periods. Serum CK activity was determined 4 hours after exercise. Plasma dantrolene concentration was measured before and 90 minutes after dosing on the first and last days of dantrolene treatment and before dosing on the first day of the inert treatment period. Results - 90 minutes after dosing, mean ± SEM plasma dantrolene concentration was 0.62 ± 0.13 and 0 μg/mL in the dantrolene and inert treatment groups, respectively. Serum CK activity was lower in dantrolene-treated horses (264 ± 13 U/L), compared with activity in water-treated horses (1,088 ± 264 U/L). Two horses displayed marked muscle stiffness on the inert treatment. Conclusions and Clinical Relevance - In 5 horses with RER from which food had been withheld, 4 mg of dantrolene/kg administered orally provided measurable, though variable, plasma concentrations and significantly decreased serum CK activity after exercise in 4 of those horses.

AB - Objective - To determine the effect of oral administration of dantrolene sodium on serum creatine kinase (CK) activity after exercise in horses with recurrent exertional rhabdomyolysis (RER). Animals - 2 healthy horses and 5 Thoroughbreds with RER. Procedure - 3 horses received 2 doses of dantrolene (4, 6, or 8 mg/kg, PO, with and without withdrawal of food) 2 days apart; 90 minutes after dosing, plasma dantrolene concentration was measured spectrofluorometrically. On the basis of these results, 5 Thoroughbreds with RER from which food was withheld received dantrolene (4 mg/kg) or an inert treatment (water [20 mL]) orally 90 minutes before treadmill exercise (30 minutes, 5 d/wk) during two 3-week periods. Serum CK activity was determined 4 hours after exercise. Plasma dantrolene concentration was measured before and 90 minutes after dosing on the first and last days of dantrolene treatment and before dosing on the first day of the inert treatment period. Results - 90 minutes after dosing, mean ± SEM plasma dantrolene concentration was 0.62 ± 0.13 and 0 μg/mL in the dantrolene and inert treatment groups, respectively. Serum CK activity was lower in dantrolene-treated horses (264 ± 13 U/L), compared with activity in water-treated horses (1,088 ± 264 U/L). Two horses displayed marked muscle stiffness on the inert treatment. Conclusions and Clinical Relevance - In 5 horses with RER from which food had been withheld, 4 mg of dantrolene/kg administered orally provided measurable, though variable, plasma concentrations and significantly decreased serum CK activity after exercise in 4 of those horses.

UR - http://www.scopus.com/inward/record.url?scp=0346025570&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346025570&partnerID=8YFLogxK

U2 - 10.2460/ajvr.2004.65.74

DO - 10.2460/ajvr.2004.65.74

M3 - Article

VL - 65

SP - 74

EP - 79

JO - American Journal of Veterinary Research

JF - American Journal of Veterinary Research

SN - 0002-9645

IS - 1

ER -